Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.383
Buy
RSI(14)
55.125
Neutral
STOCH(KDJ)(9,3,3)
74.994
Neutral
ATR(14)
0.848
Low Volatility
CCI(14)
47.042
Neutral
Williams %R
37.267
Buy
TRIX(12,20)
0.181
Sell
StochRSI(14)
0.000
Sell
Search
Smith & Nephew PLC
SNNAdd to Watchlist
31.560USD
-0.800-2.47%
Close 07-31 16:00（ET）Quotes delayed by 15 min
13.41BMarket Cap
28.08P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.47%
5 Days
+3.24%
1 Month
+9.55%
6 Months
-7.56%
Year to Date
-3.81%
1 Year
+3.27%
Key Figures
31.590Open
31.590High
1.84MVolume
28.08P/E TTM
12.92P/E Dynamic
0.752Dividend TTM
0.43%Turnover Ratio
32.330Prev. Close
31.200Low
34.15MTurnover
32.55P/E Static
2.54P/B
2.38%Div Yield TTM
4.62%ROA
38.79052wk High
0.83Volume Ratio
412.00MNet Profit
424.86MShares
1.1239EPS TTM
0.59Beta
9.14%ROE
28.40052wk Low
1.21%Amplitude
70.62%Gross Margin
13.41BMarket Cap
6.52Reward/Risk
1.06%Risk Rate
TradingKey Stock Score of Smith & Nephew PLC
Currency: USD Updated: 2026-07-31Key Insights
Smith & Nephew PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 92 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 32.94.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Smith & Nephew PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Smith & Nephew PLC Highlights
StrengthsRisks
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 6.16B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 79.37%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 79.37%.
Undervalued
The company’s latest PE is 28.08, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 30.95M shares, decreasing 27.07% quarter-over-quarter.
Held by Sarah Ketterer
Star Investor Sarah Ketterer holds 10.59M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.13.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
32.940
Target Price
+0.86%
Upside Space
Smith & Nephew PLC News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
5
analysts
Hold
Current Rating
32.940
Target Price
+0.86%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Smith & Nephew PLC
SNN
5
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
32.046
Sell
MA10
31.115
Buy
MA20
30.847
Buy
MA50
30.441
Buy
MA100
31.218
Buy
MA200
32.725
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Smith & Nephew PLC Info
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Ticker SymbolSNN
CompanySmith & Nephew PLC
CEONath (Deepak S)
Websitehttps://www.smith-nephew.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Smith & Nephew PLC (SNN)?
The current price of Smith & Nephew PLC (SNN) is 31.53.
What is the symbol of Smith & Nephew PLC?
The ticker symbol of Smith & Nephew PLC is SNN.
What is the 52-week high of Smith & Nephew PLC?
The 52-week high of Smith & Nephew PLC is 38.79.
What is the 52-week low of Smith & Nephew PLC?
The 52-week low of Smith & Nephew PLC is 28.40.
What is the market capitalization of Smith & Nephew PLC?
The market capitalization of Smith & Nephew PLC is 13.40B.
Is Smith & Nephew PLC (SNN) currently rated as Buy, Hold, or Sell?
According to analysts, Smith & Nephew PLC (SNN) has an overall rating of signal_hold, with a price target of 32.94.
What is the Earnings Per Share (EPS TTM) of Smith & Nephew PLC (SNN)?
The Earnings Per Share (EPS TTM) of Smith & Nephew PLC (SNN) is 1.44.